FDA’s “Critical Path” Initiative Presentation to FDA Science Board. Janet Woodcock, M.D. Acting Deputy Commissioner for Operations. The Challenge.
Janet Woodcock, M.D.
Acting Deputy Commissioner
schizophrenia, stroke, and many more
A serious attempt to bring attention and focus to the need for targeted scientific efforts to modernize the techniques and methods used to evaluate the safety, efficacy and quality of medical products as they move from product selection and design to mass manufacture.
“....The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.”